Trending...
- VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
- Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
- Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
CHICAGO, June 20, 2025 ~ During the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago, the Obesity Association™, a division of the ADA, announced the publication of Weight Stigma and Bias: Standards of Care in Overweight and Obesity—2025. This groundbreaking publication, along with its Introduction & Methodology section in BMJ Open Diabetes Research & Care, marks the first clinical guidance for overweight and obesity.
With approximately 110 million American adults affected by obesity and up to 53% of new cases of type 2 diabetes attributed to obesity each year, there is a pressing need for comprehensive and evidence-based guidelines to inform care. The recent symposium on Standards of Care in Overweight and Obesity 2025 Updates at the ADA's Scientific Sessions highlighted key insights on physician guidelines for weight stigma and bias. These include training for healthcare professionals, creating inclusive clinical environments, person-centered communication, shared decision making, and evidence-based interventions.
More on illi News
In addition to these important updates, researchers also discussed what is next for the clinical guidelines. This includes a potential section on pharmacologic treatment as well as a preview of what will be covered in that section.
The Standards of Care in Overweight and Obesity 2025 Updates symposium was just one of many obesity-related presentations at the ADA's Scientific Sessions. From basic research to clinical studies and implementation science, these presentations showcased groundbreaking developments in obesity treatment and care.
Some notable studies that will be presented at the annual meeting include a Phase 2 study on once-monthly MariTide for treating obesity in people with or without type 2 diabetes; outcomes from the ADJUnct Semaglutide Treatment in Type 1 Diabetes (ADJUST-T1D) trial; results from the BELIEVE study on improving weight loss while preserving lean mass; findings from the PATHWEIGH trial on weight management in primary care; data from a Phase 3 RCT of Orforglipron as monotherapy in drug-naïve type 2 diabetes; and the efficacy and safety of CagriSema in adults with overweight or obesity.
More on illi News
"The ADA's Standards of Care in Diabetes guideline is the gold standard for diabetes care and management," said Dr. Raveendhara Bannuru, the ADA's vice president of medical affairs and lead author of the guidelines. "The new Standards of Care in Overweight and Obesity guidelines stand to yield significant impact and progress in patient care, and this is just the beginning."
As part of their ongoing commitment to combating obesity, the ADA continues to develop new clinical practice guidelines and initiatives to advance the quality of care. Dr. Bannuru and other members of the Professional Practice Committee will present their findings on Standards of Care in Overweight and Obesity 2025 Updates at a symposium on Friday, June 20 from 12:45-1:45 p.m.
With these new developments, it is clear that the ADA is dedicated to improving patient care for those affected by overweight and obesity. The publication of Weight Stigma and Bias: Standards of Care in Overweight and Obesity—2025 marks a significant step towards addressing this pressing issue.
With approximately 110 million American adults affected by obesity and up to 53% of new cases of type 2 diabetes attributed to obesity each year, there is a pressing need for comprehensive and evidence-based guidelines to inform care. The recent symposium on Standards of Care in Overweight and Obesity 2025 Updates at the ADA's Scientific Sessions highlighted key insights on physician guidelines for weight stigma and bias. These include training for healthcare professionals, creating inclusive clinical environments, person-centered communication, shared decision making, and evidence-based interventions.
More on illi News
- Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
- Danholm Collection Launches Boutique Luxury Real Estate Brokerage in Central Florida
- Icarus IFE Systems Launches 3D Satellite Flight Map on Portable In-Flight Entertainment System
- Sellvia Market Expands Curated Store Portfolio for Dropshipping Sellers
- Food Journal Magazine Raises the Standard for Restaurant Reviews in Los Angeles
In addition to these important updates, researchers also discussed what is next for the clinical guidelines. This includes a potential section on pharmacologic treatment as well as a preview of what will be covered in that section.
The Standards of Care in Overweight and Obesity 2025 Updates symposium was just one of many obesity-related presentations at the ADA's Scientific Sessions. From basic research to clinical studies and implementation science, these presentations showcased groundbreaking developments in obesity treatment and care.
Some notable studies that will be presented at the annual meeting include a Phase 2 study on once-monthly MariTide for treating obesity in people with or without type 2 diabetes; outcomes from the ADJUnct Semaglutide Treatment in Type 1 Diabetes (ADJUST-T1D) trial; results from the BELIEVE study on improving weight loss while preserving lean mass; findings from the PATHWEIGH trial on weight management in primary care; data from a Phase 3 RCT of Orforglipron as monotherapy in drug-naïve type 2 diabetes; and the efficacy and safety of CagriSema in adults with overweight or obesity.
More on illi News
- Independent Multimedia IP Digi 995 Surpasses 10 Million Animated Media Views
- Mayor Brandon Johnson, Department of Environment Relaunch the Chicago Energy Benchmarking Program
- Chicago: Mayor Brandon Johnson Statement on the Firing of Kristi Noem
- Williamsville Spa Expands Team to Meet Growing Demand for Professional Facials
- Pregis Expands Wind Energy Use, Advancing Progress Toward Net Zero by 2040
"The ADA's Standards of Care in Diabetes guideline is the gold standard for diabetes care and management," said Dr. Raveendhara Bannuru, the ADA's vice president of medical affairs and lead author of the guidelines. "The new Standards of Care in Overweight and Obesity guidelines stand to yield significant impact and progress in patient care, and this is just the beginning."
As part of their ongoing commitment to combating obesity, the ADA continues to develop new clinical practice guidelines and initiatives to advance the quality of care. Dr. Bannuru and other members of the Professional Practice Committee will present their findings on Standards of Care in Overweight and Obesity 2025 Updates at a symposium on Friday, June 20 from 12:45-1:45 p.m.
With these new developments, it is clear that the ADA is dedicated to improving patient care for those affected by overweight and obesity. The publication of Weight Stigma and Bias: Standards of Care in Overweight and Obesity—2025 marks a significant step towards addressing this pressing issue.
Filed Under: Business
0 Comments
Latest on illi News
- Serina Damesworth Hired as Century Fasteners Corp. – Director of Quality
- Monsters of the Meat-Way: The Original Mr. Beef Brings Juicy Chicago Flavor to Midway International Airport
- Chicagoland Named #1 U.S. Metro for Corporate Relocation and Site Selection
- Digi 995: Awakening Launches Sci-Fi Mobile Battle Arena Across All Major Platforms
- Naperville Police Assist in Multi-Agency Investigation Leading to the Arrest of a DuPage County Man Charged with Gunrunning, Possessing Machine-Gun Conversion Devices
- National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
- Distributed Social Media - Own Your Content
- Tarrytown Expocare Pharmacy Announces Strategic Leadership Appointments to Accelerate Growth and Innovation
- New Environmental Thriller "The Star Thrower" Reimagines a Classic Lesson in Individual Impact
- Summit Appoints Javier Cabeza as Data, AI, and Analytics Practice Lead
- March Is Skiing's Smartest Buying Window
- Cancun Airport Transportation Expands Fleet Ahead of Record Passenger Growth at Cancun International Airport
- Tobu Group's "T-home Series" of Accommodations in Tokyo Just Opened "T-home KEI."
- Custom Wooden Token Manufacturer Celebrates 10 Years of Helping Brands Stay Top of Mind
- NaturismRE Launches the NRE Health Institute to Advance Evidence-Informed Public Health Research
- P-Wave Classics to publish Robert Bage's Hermsprong in three volumes, beginning 12 May
- Naperville: Firefighters Battle Structure Fire in 1100 Block of Burke Court
- Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
- CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
- Naperville Police Arrest Aurora Convicted Felon Charged with Possessing Multiple Firearms Including Machine Gun